(Q53950071)

22 May 2018

title

Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis. (English)

1 reference

22 May 2018

primary biliary cholangitis

main subject

0 references

author name string

Ricci P

1

1 reference

22 May 2018

Hofmann AF

2

1 reference

22 May 2018

Hagey LR

3

1 reference

22 May 2018

Jorgensen RA

4

1 reference

22 May 2018

Rolland Dickson E

5

1 reference

22 May 2018

Lindor KD

6

1 reference

22 May 2018

publication date

1 June 1998

1 reference

22 May 2018

Digestive Diseases and Sciences

published in

1 reference

22 May 2018

volume

43

1 reference

22 May 2018

issue

6

1 reference

22 May 2018

page(s)

1292-1295

1 reference

22 May 2018

https://scigraph.springernature.com/pub.10.1023/a:1018868126743

exact match

0 references

cites work

Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis

1 reference

12 December 2020

Effect of cholylsarcosine on hepatic cholesterol and bile acid synthesis and bile secretion in rats

1 reference

12 December 2020

Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions

1 reference

12 December 2020

Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation

1 reference

12 December 2020

Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study

1 reference

12 December 2020

Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine

1 reference

12 December 2020

Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis

1 reference

12 December 2020

Bile salt-membrane interactions and the physico-chemical mechanisms of bile salt toxicity.

1 reference

12 December 2020

Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans.

1 reference

12 December 2020

Pruritus associated with cholestasis. A review of pathogenesis and management

1 reference

12 December 2020

Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment

1 reference

12 December 2020

Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection

1 reference

12 December 2020

The protective effect of hydrophilic bile acids on bile acid hepatotoxicity in the rat

1 reference

12 December 2020

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study

1 reference

12 December 2020

Metabolism of ursodeoxycholic acid in man

1 reference

12 December 2020

Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.

1 reference

12 December 2020

Effects of cholestasis on membrane flow and surface polarity in hepatocytes

1 reference

12 December 2020

Effects of plasma exchange (PE) in primary biliary cirrhosis (PBC). A pilot study.

1 reference

12 December 2020

Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Medical therapy of pruritus of cholestasis.

1 reference

12 December 2020

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018868126743

1 reference

22 May 2018

Dimensions Publication ID

1051954000

0 references

1 reference

22 May 2018